Gold-Loaded Porphyrin Nanodots Ease Kidney Injury in Mice

Acute kidney injury strikes fast, and medicine still has no dependable drug to stop it. A team writing in Gold Bulletin now reports a possible way forward built from surprisingly small parts: nanodots roughly ten nanometers across, made of a porphyrin molecule loaded onto gold-functionalized polymeric particles. In cell cultures and in mice with cisplatin-induced kidney damage, these porphyrin-loaded Au-functionalized polymeric nanodots, or P-APNDs, gathered preferentially in the kidneys and showed strong antioxidant activity, and treated animals recovered key markers of kidney function.

The rationale behind the design is a marriage of chemistry and anatomy. Porphyrins are aromatic, intensely colored molecules that can self-assemble on surfaces and in solution, and they are prized for their flexible electronic and binding properties. Coating them with gold nanoparticles stabilizes the compound, because the binding involves all of the iminic nitrogen atoms in the porphyrin rings, which sit parallel to the nanoparticle surface. The researchers describe this coupling of porphyrins and gold clusters as π-metal coupling. Nanodots themselves, ranging from two to eight nanometers, offer photochemical stability, biocompatibility, photoluminescence, and water solubility, and their surfaces can be readily modified with functional groups.

Size matters for another reason: the kidney’s own filtration architecture. For nanoparticles to exit the body through renal filtration, they must slip through the 100-nanometer fenestrae of the glomerular endothelial cells and the 10-nanometer pores of the podocyte slit diaphragm. Nanodots, by virtue of their diminutive size, can permeate this glomerular filtration barrier. That anatomical window is what the team hoped to exploit, delivering renoprotective antioxidant capacity precisely where oxidative stress does its damage. Overproduction of reactive oxygen species is a central driver of acute kidney injury, alongside ischemic reperfusion, sepsis, and drug toxicity.

The synthesis was deliberately simple. Polymeric nanodots were made at a starting mass ratio of PEG to gold to ascorbic acid of 66:20:10, with the mixture stirred and then dialyzed against deionized water for 24 hours. Porphyrin was then loaded in by reprecipitation: the nanodots and porphyrin molecules were dissolved in tetrahydrofuran, injected into water under sonication, heated to 100 to 120 degrees Celsius under nitrogen to evaporate the solvent, and filtered to yield a homogeneous P-APND suspension. Drug loading was quantified by ultrafiltration and ultraviolet-visible spectrophotometry, and release was tracked with a dialysis bag diffusion method across pH 4, 5, 6.8, and 7.4.

Characterization confirmed the construct. FTIR spectra showed peaks consistent with C-H bending and C-O-C stretching after porphyrin loading, with diminished C=O and C-O band intensities and two stronger bands between 1650 and 1355 per centimeter, evidence of conjugation between the two compounds. X-ray diffraction revealed peaks matching a face-centered cubic closely packed arrangement resembling metallic gold, with little change upon porphyrin combination, indicating that crystallinity was preserved. Scanning electron microscopy suggested particle diameters of roughly 20 to 25 nanometers, while transmission electron microscopy showed spherical particles mostly within the 10-nanometer range, and dynamic light scattering gave a value of 8.25 nanometers. The average drug encapsulation efficiency and loading capacity were 60 percent and 5.5 plus or minus 2.1 percent by weight, respectively.

Stability and release behavior rounded out the materials profile. Under continuous 254-nanometer ultraviolet exposure, no photobleaching occurred even after 100 minutes, confirming excellent photostability. The zeta potential measured minus 5.05 millivolts, a negative value the authors note enhances colloidal stability, and thermogravimetric analysis showed a weight loss of about 2.56 percent completed at 440 degrees Celsius, attributed to loss of the porphyrin’s organic moieties. Drug release was fastest under acidic conditions: around 80 percent of the payload was released within 10 hours, with no further release detected after 12 hours, and maximum release occurred at pH 4 and 5, likely because reduced interactions between porphyrin and the nanodot weaken hydrogen bonds and electrostatic attractions in acid.

The antioxidant performance was tested head-to-head against the unloaded particles. In ABTS, superoxide, and DPPH radical scavenging assays, P-APNDs outperformed both APND and PND controls, with scavenging efficacy rising with concentration. Porphyrins are known to modulate redox homeostasis, converting reactive oxygen species into less harmful substances such as water and oxygen, and the gold component appears to enhance that capability. The authors suggest the sustained release profile prolongs antioxidant activity and could reduce the need for frequent dosing, though that remains a preclinical observation rather than a demonstrated clinical benefit.

In human embryonic kidney cells, the nanodots proved benign and protective. At 10 micrograms per milliliter, PND, APND, and P-APND showed no toxicity, with P-APND maintaining roughly 90 percent cell viability. When HEK 293 cells were damaged with cisplatin at 25 micromolar, or stressed with hydrogen peroxide or hypoxia, P-APND treatment reduced intracellular reactive oxygen species measured with a DCF-DA fluorescence probe, restored mitochondrial membrane potential as judged by JC-1 staining, and lowered apoptosis rates seen in DAPI staining and Annexin V/propidium iodide flow cytometry. The protective effect peaked at 10 micrograms per milliliter, which the authors interpret as evidence of efficacy at low concentrations.

The in vivo results are the heart of the paper. Mice given intraperitoneal cisplatin at 10 or 15 milligrams per kilogram developed acute kidney injury, and a single tail-vein dose of P-APND, 200 microliters at 2 milligrams per milliliter, was then tracked. Biodistribution imaging showed kidney-specific accumulation, with 60 to 70 percent of the injected dose present in the kidney after 24 hours and minimal signal in the heart, spleen, and lungs. Urinary recovery of the drug was low, consistent with substantial retention in renal tissue. Treated mice showed reduced serum creatinine and blood urea nitrogen, restored serum albumin and beta-2-microglobulin, lower kidney injury scores on histopathology, and reduced inflammatory cytokines including TNF-alpha, IL-4, IL-6, and NF-kappa-B. Oxidative stress markers moved in the protective direction as well: malondialdehyde fell while glutathione and superoxide dismutase activity rose. Body weight remained constant and organ morphology showed no significant changes, which the authors read as biocompatibility.

The authors are candid that this is early work. They note that therapeutic efficacy and safety require further evaluation in comprehensive animal models and clinical settings, that synthesis may face challenges in scaling for therapeutic applications, and that the restricted AKI models used may not reflect all clinical conditions. The study was approved by the Ethical Committee of the Shanxi Academy of Medical Sciences, and all experiments were run at least three independent times with data reported as means plus or minus standard deviation. Still, the convergence of renal targeting by size, porphyrin-driven radical scavenging, and measurable functional recovery in a cisplatin model makes P-APNDs a candidate worth watching. The team’s stated next step is testing in large animal models and exploring how such nanodots might be woven into clinical nursing care for patient management, a reminder that even the most elegant nanomedicine must eventually prove itself outside the laboratory.

Subject of Research: Porphyrin-loaded gold-functionalized polymeric nanodots for treating acute kidney injury through renal accumulation and antioxidant activity

Article Title: The efficacy of porphyrin-loaded Au-functionalized polymeric nanodots alleviates acute kidney injury and nursing care via preferential renal accumulation and antioxidant capacity

Article References: Kang, Y., & Zhang, J. (2025). The efficacy of porphyrin-loaded Au-functionalized polymeric nanodots alleviates acute kidney injury and nursing care via preferential renal accumulation and antioxidant capacity. Gold Bulletin, 58(1), Article 2. https://doi.org/10.1007/s13404-024-00355-5

Image Credits: AI Generated

DOI: 10.1007/s13404-024-00355-5

Keywords: acute kidney injury, porphyrin, gold nanoparticles, polymeric nanodots, antioxidant, cisplatin nephrotoxicity, renal accumulation, reactive oxygen species, nanomedicine, kidney injury score, HEK 293 cells, drug delivery